Promise Tracker
0 delivered, 0 close, 2 missed.
View Promises →SBI Life delivered a strong H1 FY24 with PAT up 19% YoY to INR 7.6B, driven by 24% growth in new business premium to INR 162.6B and private market leadership at 24.7% share.
Financial stats pending filing verification
SBI Life delivered a strong H1 FY24 with PAT up 19% YoY to INR 7.6B, driven by 24% growth in new business premium to INR 162.6B and private market leadership at 24.7% share. Individual APE grew 17% to INR 71.4B, aided by robust agency expansion (33% agent growth) and ULIP demand. VoNB margin held steady at 28.6% despite higher ULIP mix, supported by repricing of non-par and annuity products. Management reaffirmed 20% full-year individual APE growth guidance, with focus on maintaining a 55/45 ULIP/non-ULIP mix. Key risks include equity market volatility impacting ULIP sales and potential margin pressure from rising commission costs under new IRDAI norms.
SBI लाइफ ने चालू वित्त वर्ष की पहली छमाही में शानदार प्रदर्शन किया। कंपनी का मुनाफा पिछले साल की तुलना में 19% बढ़कर 760 करोड़ रुपये हो गया। नए बीमा प्रीमियम में 24% की वृद्धि हुई और बाजार में 24.7% हिस्सेदारी के साथ कंपनी निजी क्षेत्र में अग्रणी बनी रही। व्यक्तिगत बीमा प्रीमियम 17% बढ़कर 7,140 करोड़ रुपये हो गया, जिसमें एजेंटों की संख्या में 33% वृद्धि और ULIP (बाजार से जुड़ी बीमा योजना) की मांग ने मदद की। कंपनी का मार्जिन 28.6% पर स्थिर रहा। प्रबंधन ने पूरे साल 20% वृद्धि का लक्ष्य दोहराया है। हालांकि, शेयर बाजार में उतार-चढ़ाव और नए नियमों से कमीशन बढ़ने का जोखिम है।
0 delivered, 0 close, 2 missed.
View Promises →Equity market volatility impacting ULIP sales
View Risks →Full transcript text is available on this route.
Read Transcript →Gained 169 bps market share in individual new business premium, maintaining leadership.
Persistency remained strong; 49-month and 61-month persistency improved by 92 bps and 509 bps respectively.
Agency channel individual APE grew 35% YoY, driven by agent additions and productivity gains.
AUM grew 22% YoY to INR 3.45 trillion, reflecting strong investment performance and inflows.
Management reaffirmed 20% growth guidance for FY24 individual APE, despite H1 growth of 17%.
VoNB margin expected to remain within 28%-30% for FY24, supported by product mix and repricing actions.
Management aims to achieve a 55/45 product mix between ULIP and non-ULIP, though market conditions may influence near-term mix.
Management expects to deliver better than industry growth, targeting 20-25% growth in individual rated premium for FY24.
Management expects VNB margins to stay in the 28-30% range, with no significant expansion or compression expected.
CFO indicated non-par share should normalize to around 24-25% of business for the full year, similar to FY23.
A sharp market downturn could reduce ULIP demand, affecting growth and product mix targets.
New commission guidelines may increase payout ratios, pressuring margins if not offset by mix changes.
While improving, reinsurance terms remain cautious; slower normalization could cap protection growth.
Regulatory changes (EOM guidelines) may lead to higher commission payouts, especially to SBI, potentially compressing VNB margins.
13-month and 25-month persistency dipped slightly, which could impact future renewal premiums and embedded value if not reversed.
Last year's exceptional Q1 growth (86% in individual rated) creates a high base; sustaining 20%+ growth for the full year requires strong performance in subsequent quarters.
Management reaffirmed 20% growth guidance for FY24 individual APE, despite H1 growth of 17%.
A sharp market downturn could reduce ULIP demand, affecting growth and product mix targets.
View Risks →